| Relationship between 18F-FDG PET/CT radiometabolic markers and EGFR mutation, positive ALK Expression in patients with non-small cell lung cancer | Mine GAYAF,Nimet AKSEL,Ahmet Emin ERBAYCU,Hakan KOPORAL,Ceyda ANAR | 437–448 |
| Efficacy of pulmonary rehabilitation on patients with non-cystic bronchiectasis according to disease severity | Sami DENİZ,Hülya DOĞAN ŞAHİN,Ahmet Emin ERBAYCU | 449–457 |
| Influenza viruses and SARS-CoV-2 in adult: ‘Similarities and differences’ | Şerife TORUN,Berna BOTAN YILDIRIM,Çağrı KESİM,Aynur SÜNER,Özgür ÖZEN,Şule AKÇAY | 458–468 |
| Comparison of the effectiveness of high-flow and conventional nasal cannula oxygen therapy in pulmonary embolism patients with acute hypoxemic respiratory failure | Alperen AKSAKAL,Leyla SAĞLAM,Buğra KERGET,Elif YILMAZEL UÇAR | 469–476 |
| A prospective observational evaluation of treatment outcomes of patients with chronic obstructive pulmonary disease and peripheral blood eosinophilia | Burcu BARAN KETENCİOĞLU1, Nuri TUTAR, İnci GÜLMEZ, Fatma Sema OYMAK, İnsu YILMAZ, Figen ARSLANTAŞ | 477–485 |
| Contribution of artificial intelligence applications developed with the deep learning method to the diagnosis of COVID-19 pneumonia on computed tomography | Nevin AYDIN,Özer ÇELİK | 486–491 |
| Pulmonary fibrotic-like changes on follow-up chest CT exam in patients recovering from COVID-19 pneumonia | Ahmet VURAL,Ahmet KAHRAMAN | 492–498 |
| Clinical characteristics of lung cancer patients with COVID-19: Retrospective case series | Yusuf KAHYA,Buse Mine KONUK,Cabir YÜKSEL,GÜLE ÇINAR,Kemal OSMAN MEMİKOĞLU | 499–509 |
| Can diaphragm excursion predict prognosis in patients with severe pneumonia? | Aslıhan GÜRÜN KAYA,Elvan Burak VERDİ,Sema Nur SÜSLÜ,Miraç ÖZ,Serhat EROL,Fatma ÇİFTÇİ,Aydın ÇİLEDAĞ,Akın KAYA | 510–519 |
| Long-term macrolide therapy in asthma | İnsu YILMAZ, Gülden PAÇACI ÇETİN, Bahar ARSLAN | 520–534 |
| Güncel çalışmalar ışığında ARDS’de mevcut durum: Sınıflandırma, epidemiyoloji ve farmakoterapötikler | Fatma YILDIRIM,İrem KARAMAN,Akın KAYA |